Z650 in Advanced Esophageal Squamous Cell Carcinoma With EGFR Over Expression or Gene Amplification
Clinical trial NCT03888092 · COMPLETED
Trial details
- NCT number
- NCT03888092
- Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-18
- Primary completion
- 2022-12-13
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.